|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||201.26 - 204.73|
|52-week range||201.26 - 204.73|
|Beta (5Y monthly)||0.68|
|PE ratio (TTM)||20.76|
|Earnings date||02 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
Amgen Inc. ( NASDAQ:AMGN ) stock is about to trade ex-dividend in four days. The ex-dividend date occurs one day before...
(Bloomberg) -- Hummingbird Bioscience, a Singaporean clinical-stage biotechnology firm, is considering fundraising options including an initial public offering, according to people familiar with the matter.The company is interviewing investment banks as it weighs alternatives, which also include a private funding round, the people said, asking not to be identified because the matter is private.Hummingbird could seek to raise about $200 million to $300 million in a share sale, which could take pl